用户名: 密码: 验证码:
消极认知偏差—胰腺癌不良预后的实证模型研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
第一部分负性情绪筛查以及消极认知偏差测查工具在胰腺癌患者中的应用
     目的:探讨负性情绪筛查以及消极认知偏差测查工具在胰腺癌患者中的适用性,并比较胰腺癌患者与社区正常对照组在情绪以及负性认知中的特征。
     方法:选择2009年7月至2011年12月期间在湖南5所三甲医院选取胰腺癌共1029人,男性545例,女性484例,以及472名社区对照者完成以下3个量表:心境与焦虑症状问卷简式(MASQ-SF),认知失调性态度问卷(DAS)与认知方式问卷(CSQ)。采用下列方法检验认知情绪调节问卷的信度:(1) Cronbach a系数:主要检验量表的同质性信度。(2)条目间平均相关系数(mean inter-term correlation):通过计算总量表、各分量表的条目间两两相关的均值,检验量表的同质性。(3):重测信度:主要检验量表的跨时间的稳定性。效度检验包括结构效度(验证性因素分析)以及聚合与区分效度。采用t检验比较两组样本在焦虑抑郁的情绪问题中的区别以及负性认知偏差的特征。采用量表间的相关评估CERQ-C的聚合与区分效度。采用独立样本t检验比较胰腺癌患者的负性情绪问题以及消极偏差特征的性别差异。
     结果:(1)量表得分情况:胰腺癌患者组与社区对照组得分在负性情绪的各个因子均有显著差异,并且胰腺癌患者有更多的消极的功能失调性态度。而男女患者在负性情绪总分及各因子得分上均无显著差异,但是胰腺癌患者在消极认知偏差的因素中受试者得分具有显著的性别差异。(2)信度:胰腺癌患者组:(1)心境与焦虑症状问卷的总量表的内部一致性系数α=0.88,各量表α系数在0.79-0.93之间。(2)功能失调性态度问卷的内部一致性系数为α=0.75;(3)认知方式问卷的内部一致性系数为α=0.79。社区对照组:(1)心境与焦虑症状问卷的总量表的内部一致性系数α=0.88,(2)功能失调性态度问卷的内部一致性系数为α=0.79,(3)认知方式问卷的内部一致性系数为α=0.80。(2)条目间平均相关系数:胰腺癌患者组:心境与焦虑症状问卷的总量表的条目间平均相关系数为0.29,功能失调性态度问卷的总量表条目间平均相关为0.33,而认知方式问卷的总量表条目平均相关系数为0.33,社区对照组:心境与焦虑症状问卷的总量表的条目间平均相关系数为0.31,而功能失调性态度问卷的总量表条目间平均相关为0.31,而认知方式问卷的总量表条目平均相关系数为0.29。重测信度:胰腺癌患者组:心境与焦虑症状问卷的总量表的1.5个月的重测信度为0.80,功能失调性态度问卷的重测信度为0.72,而认知方式问卷的重测信度为0.66。社区对照组:心境与焦虑症状问卷的总量表的1.5个月的重测信度为0.71,功能失调性态度问卷的重测信度为0.71,而认知方式问卷的重测信度为0.71.(3)结构效度:验证性因素分析结果显示,在胰腺癌患者样本以及社区对照组样本中,心境与焦虑症状问卷的模型的拟合指数良好:拟合指数;X2/df分别为2.19和2.83,均接近2并小于5;CFI、IFI、TLI均大于0.90;RMSEA均小于等于0.08。在胰腺癌患者样本以及社区对照组样本中认知方式问卷的模型的拟合指数良好:拟合指数;X2/df分别为2.22和3.91,均接近2并小于5;CFI、IFI、TLI均大于0.90;RMSEA均小于等于0.08。聚合与区分效度:心境与焦虑症状问卷以及认知方式问卷各分量表间及与总量表间的相关分析,各分量表间及各分量表与总量表的相关性,如表2-6所示,胰腺癌患者组的分量表与总量表之间的相关系数以及分量表之间的相关系数均有显著性意义,而社区对照组的分量表与整个量表之间的相关系数以及各个分量表间的相关系数均有显著性意义。
     结论:负性情绪筛查工具以及消极认知偏差测评工具在胰腺癌患者中,显示了良好的信、效度,可以协助评价胰腺癌患者的情绪问题以及消极认知偏差问题,对胰腺癌患者的治疗与护理提供新的思路与理论依据
     第二部分认知高风险胰腺癌患者心理特征以及临床症状特征
     目的:探讨高低风险的胰腺癌患者心理特征以及初步探讨其临床症状的特点,以期从心理病理学角度了解胰腺癌患者的心理与生理症犬的发生机制。并用数理建模的方法构建心理因素影响心身症状的机制。
     方法:从参与第一部分的胰腺癌患者中根据认知高风险个体筛选示准筛选出认知高风险胰腺癌患者共129名患者,而同时选择在两个司卷中均得分后25%的患者作为认知低风险的胰腺癌患者作为比较,共159人。被试按照每个心理测评量表的标准指导语完成以下量表:生活质量综合评定问卷(Generic Quality of Life nventory-74,GQOLI-74);医院焦虑抑郁量表(The Hospital Anxiety md Depression Scale, HAD);认知失调性态度问卷(Dysfunctional Attitude Scale, DAS);心境与焦虑症状问卷简式(Mood and Anxiety ymptom Questionnaire-Short Form, MASQ-SF);认知方式问卷(Cognitive Style Questionnaire,CSQ)。以及患者疼痛分级程度评估法(NRS)评估胰腺癌患者的疼痛体验。计量资料采用均数±标准差,两组间比较用t检验,两组以上组间比较用方差分析。结构方程的建模采用AMOS6.0版本完成。
     结果:两组受试者得分在情绪状况得分中均具有显著差异,认知高风险组胰腺癌患者有更多的总体的负性情绪问题,并在焦虑,抑郁的各个分量表中也显著高于低认知风险组的个体。高认知风险胰腺癌患者在功能失调性态度的大部分分量表得分均高于低认知风险的胰腺癌患者组,且均具有显著性差异(P<.05)。两组受试者在对自身,对负性生活事件发生的理解以及对未来的期望等方面的得分均具有显著差异。高认知风险胰腺癌患者在认知方式的各个分量表得分均高于低认知风险的胰腺癌患者组,且均具有显著性差异.各个分量表分别与抑郁症状呈显著正相关;而功能失调性态度以及自身稳定性归因与疼痛得分显著正相关。而在控制其他分量表影响后,功能失调性态度以及自我归因仍与抑郁,焦虑症状呈显著正性相关(均P<0.05),而控制其他分量表影响后,功能失调性态度总分仍与疼痛得分显著正相关。为进一步验证消极认知策略对焦虑和抑郁症状以及胰腺癌患者疼痛的预测作用,采用多元回归分析来评估功能失调性态度以及认知方式策略与抑郁和焦虑症状以及胰腺癌疼痛的关系,第一步性别进入回归方程,第二步不同的认知策略同时进入回归方程。多元回归分析的结果提示,排除性别差异,功能失调性态度可以独立预测抑郁与焦虑症状的发生。而胰腺癌患者在应对胰腺癌的打击时,使用以下策略越多,抑郁和焦虑症状也越多:功能失调性态度,自我归因以及持久的归因等。而在验证消极认知策略对疼痛的预测中,,采用多元回归分析来评估功能失调性态度以及认知方式策略与胰腺癌疼痛的关系,第一步性别进入回归方程,第二步不同的认知策略同时进入回归方程。结果发现,功能失调性态度可以独立影响疼痛的程度,而具有持久性归因的患者,其疼痛的程度也更大。本研究采用了结构方程模型建立策略,先根据理论假说设定多个模型,通过模型比较得到一个统计上可以接受,合符理论依据的相对有效和节俭的模型。结果发现模型2的模型拟合最佳,卡方值最小,并且X2/df(2.463)和RMSEA(0.068)均小于模型1,而CFI(0.93)、IFI (0.92)和GFI(0.94)均大于模型1,且理论支持充分,所以,模型2为最佳模型。消极认知策略影响患者的对疾病的态度以及观念,从而影响患者的情绪以及疼痛体验。即消极认知策略对胰腺癌病人情绪以及生理性疼痛的影响不是通过直接效应,而是通过间接效应,即消极认知策略是通过功能失调性态度这个中介变量作用,并影响了患者情绪以及疼痛的状况。
     结论:消极认知偏差高风险的胰腺癌患者有更多的情绪问题,生活质量问题,以及更严重的癌性疼痛的体验。
Part Ⅰ The application of Negative emotions and negative screening test of cognitive bias search tool in pancreatic cancer patients
     Objective:The aim of the present study was to study the applicability of negative emotions and negative screening test of cognitive bias tool in the patients with pancreatic cancer and to compare the pancreatic cancer patients with community control group in the emotional and negative cognitive features.
     Methods:This study included1029patients and472normative subjects. All of the subjects completed the Chinese version of the Mood and Anxiety Symptom Questionnaire-Short Form,(MASQ-SF); Dysfunctional Attitude Scale,(DAS) and Cognitive Style Questionnaire (CSQ). We calculated the mean inter-item correlations for the total Scale and for each of the subscales. Cronbach's alpha coefficients to analyze the inter-correlations and reliability. We utilized confirmatory factor analysis to do measurement model A one-way multivariate analysis of variance (MANOVA) was computed to examine the effects of gender.
     Results:(1) Scale scores:negative emotion scores in patients with pancreatic cancer group and the community control group were significantly different in all factors and pancreatic cancer patients have more negative dysfunctional attitudes. Negative emotion score in Male and female patients and factor scores were not significantly different, but the negative cognitive bias the pancreatic cancer patients in factor score of the subjects had significant gender differences.(2) Reliability:The pancreatic cancer group:(1) the total scale's internal consistency coefficient of mood and anxiety symptoms questionnaire is0.88, and all subscales between0.79to0.93.(2) Dysfunctional attitude questionnaire: internal consistency coefficient (a=0.75);(3) internal consistency coefficient for cognitive style questionnaire is0.79. Community control group:(1) total scale internal consistency coefficient for mood and anxiety symptoms questionnaire is0.88,(2) internal consistency coefficient of Dysfunctional attitude questionnaire is0.79,(3) The internal consistency coefficient for Cognitive Style Questionnaire is0.80(2) The average correlation coefficient between items:pancreatic cancer group:mood and anxiety symptom questionnaire entries in the table between the total amount of the average correlation coefficient is0.29, the average correlation for the total scale of dysfunctional attitudes questionnaire was0.33and the total amount of the average correlation coefficient for the cognition Style Questionnaire was0.33. The community control group:the total amount of the correlation coefficient for the mood and anxiety symptom questionnaire is0.31, while the
     Dysfunctional Attitude average correlation between the total table entries0.31, while the cognitive style questionnaire table entry total average correlation coefficient is0.29.(3) Construct validity:confirmatory factor analysis showed that samples of pancreatic cancer patients and the community in the control group sample have a good model fit index of mood and anxiety symptoms questionnaire. The convergent and discriminant validity:The correlation between subscales and total scale of mood and anxiety symptom questionnaire and the cognitive style questionnaire ient between the correlation coefficients between subscales were significant.
     Conclusion:Negative emotions-and negative cognitive bias screening tool assessment tool in pancreatic cancer patients, showed good reliability and validity, can assist in evaluating the emotional problems of patients with pancreatic cancer and negative cognitive bias problem, to provide new ideas in pancreatic cancer patients Treatment and care.
     Part I The use of the Cognitive Emotion Regulation Questionnaire Chinese Version (CERQ-C) in a hypertensive subject
     Objective:The aim of the present study was to develop a Chinese version of the Cognitive Emotion Regulation Questionnaire (CERQ-C) and to examine its psychometric properties in both hypertensive and normative subjects.
     Methods:This study included434hypertensive patients and462normative subjects. All of the subjects completed the Chinese version of the Cognitive Emotion Regulation Questionnaire,(CERQ); Dysfunctional Attitude Scale,(DAS); Mood and Anxiety Symptom Questionnaire Short Form,(MASQ-SF); Center for Epidemiologic Studies Depression Scale,(CES-D). We calculated the mean inter-item correlations for the total CERQ-C and for each of the subscales. Cronbach's alpha coefficients to analyze the inter-correlations and reliability. When examining the nine-factor model, we utilized confirmatory factor analysis. The measurement model consisted of nine first-order factors (self-blame, acceptance, rumination, positive refocus, refocus on planning, positive reappraisal, putting into perspective, catastrophizing, and blaming others). A one-way multivariate analysis of variance (MANOVA) was computed to examine the effects of gender. Results:(1) The Cognitive Emotion Regulation strategies hypertension patients and normative sample most frequently used were positive reappraisal. Hypertensive group reported significantly higher scores than normative sample on Rumination (12.19±2.51/11.51±2.60,p<0.001) and catastrophizing (8.82±2.19/8.11±2.70, p<0.001), blaming others (10.76±2.11/9.88±2.48, p<0.001) and significantly lower scores than normative sample on positive reappraisal (13.80±3.55/14.71±4.11,p<0.001)(2)reliability:In hypertension group the Cronbach's alpha for the Total CERQ-C was0.80, and the Cronbach's alpha coefficient for the nine subscale ranged from0.71(Self-blame) to0.90(Rumination). And in normative group the Cronbach's alpha for the Total CERQ-C was0.79, and the Cronbach's alpha coefficient for the nine subscale ranged from0.71(Positive Reappraisal) to0.90(Rumination). The mean inter-item correlation coefficient for the nine subscale ranged from0.21-0.42(hypertension group)/0.19-0.32(normative group). In hypertension group, the test-retest reliability of the total scale was0.82, the test-retest reliability of nine subscales ranged from0.73to0.92; And in normative group, the test-retest reliability of the total scale was0.79, the test-retest reliability of nine subscales ranged from0.71to0.88.(3) Confirmatory factor analysis:The results of our CFA suggest that the nine first-order factors data fit the both two sample well.(X2/(df)=2.28, p<0.001,CFI=0.91, IFI=0.92, RMSEA=0.05, TLI=0.944)/(x2/(df)=2.34, p<0.001,CFI=0.91, IFI=0.91, RMSEA= 0.08, TLI=0.90).(4):Convergent and discriminate validity:In hypertensive group Self-blame(y=0.14, p<0.01), catastrophizing (y=0.55, p<0.001), blaming others (γ=0.47,p<0.001) were positively correlated with the total scores of Dysfunctional Attitude Scale. And Positive Refocusing (t=-0.21, p<0.01), Putting into Perspective (y=-0.27,p<0.01) were negatively correlated with the total scores of Dysfunctional Attitude Scale. In normal group, Self-blame(y=0.37, p<0.001), Rumination (t=0.61, p<0.001), catastrophizing (γ=0.67, p<0.001), blaming others (γ=0.49, p<0.001) were positively correlated with the total scores of Dysfunctional Attitude Scale. Refocus on Planning (y=-0.27,p<0.001), Putting into Perspective (t=-0.33,p<0.001) were negatively correlated with the total scores of dysfunctional Attitude Scale.
     Conclusion:The properties of CERQ-C met the psychometrics standard indicated that it is a reliable and valid assessment of cognitive emotion regulation strategies, and can be considered as an appropriate tool for assessing
     Part2Study on the Cognitive Emotion Regulation strategies of the hypertension patients with depression
     Objective:We study on the cognitive emotion regulation strategies and dysfunctional attitudes of the hypertension patients with or with not depression. Following a psychosocial perspective to study in the onset of depression.
     Methods:Recruiting1400hypertensive patients with depression from those patients recorded in the "Family Home of Hypertensive patients" and the out-patients with essential hypertension. Screening hypertension sufferers with the Hospital Anxiety and Depression Scale (HAD), the subjects with positive results (HAD>9) were evaluated with HAMA and HAMD.250patients enter the hypertension with depression group from263patients with positive screened result (HAMD>20, HAMA<14). And250hypertension patients with no depression as member of hypertension with no depression group.462normative subjects as member of normative group. All of the them completed the Hospital Anxiety and Depression Scale,(HAD), Cognitive Emotion Regulation Questionnaire,(CERQ), Dysfunctional Attitude Scale,(DAS)、Hamilton Anxiety Scale,(HAMA), Hamilton Depression Scale,(HAMD).
     Results:Significant differences were found in the use of Cognitive Emotion Regulation strategies between the three group (Wilks' Lambda=0.79, P=0.001, Hotelling's Trace=0.04, P=0.001).On the Self-blame, Positive Reappraisal, normative group reported significantly highest scores, hypertension with no depression group ranked second, and hypertension with depression group reported significantly lowest score. On Acceptance, Refocus on Planning factors, lower in hypertension with depression group than normative group and higher than hypertension with no depression group. On Rumination and Catastrophizing factors, lower in normative group than hypertension with depression group and higher than hypertension with no depression group. On Positive Refocusing, lower in normative group than hypertension with no depression group and higher than hypertension with depression group. On Putting into Perspective, lower in hypertension with depression group than hypertension with no depression group and higher than normative group. On the Blaming Others factor, lower in hypertension with no depression group than hypertension with depression group and higher than normative group. Significant differences were also found in the dysfunctional attitude between the three group.(Wilks' Lambda=0.67, P=0.001, Hotelling's Trace=0.05, P=0.001)
     A comparison among the two competitive models using SEM showed that the model-2was the optimal model, with better fit indexes than the others (X2/df (1.882), RMSEA (0.063), CFI (0.932), IFI (0.911), GFI (0.921)), and with the most parsimonious path(p<0.01).
     Conclusion:Patients of hypertension with depression more use Rumination, Catastrophizing and blame others et al negative Cognitive Emotion Regulation strategies and exists dysfunctional attitudes.
     Part3The effect of Antidepressant and Psychological Intervention on the Quality of Life and Blood Pressure of Hypertensive Patients with Depression
     Objective:The effects of antidepressant and psychological intervention on the blood pressure and quality of life in hypertension patients with depression were investigated
     Methods:After evaluating1400patients with essential hypertension by Hospital Anxiety and Depression Scale (HAD), patients with HAD positive result were evaluated with Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA). The subjects with positive results with HAMD were randomly divided into antidepressant and psychological intervention group (n=30, routine treatment, mental state intervention and the usage of antidepressant(seroxat)) and control group (n=30, only routine treatment).The effect of blood pressure control, the quality of life and the level of depression were compared between2groups.
     Results The depression symptoms were significantly improved in antidepressant and psychological intervention group compared to control group. The HAMD score fell from30.03±1.83at time of entrance to17.43±1.96at time of the study end; The blood pressure control were more effective with antidepressant and psychological intervention, The mean SBP and DBP decreased by26.17mmHg and13.63mmHg in antidepressant and psychological intervention group, while there were only14.32mmHg and7.18mmHg decrease in SBP and DBP respectively in control group; And the antidepressant and psychological intervention group have higher score quality of life. The total score of GQOLI-74has risen from65.97±4.68before treatment to71.20±5.13after treatment.
     Conclusion:The treatment of psychological intervention and usage of antidepressant could improve the control of blood pressure and quality of life in hypertensive patients.
引文
[1]American Cancer Society. (2008). Cancer facts and figures 2008. Atlanta, GA: Author.
    [2]Jemal A, Siegel R, Ward E, et al. Cancer statistics,2007. CA Cancer J Clin,2007,57(1):43-66.
    [3]Bogoevski D, Strate T, Yekebas EF, et al. Pancreatic cancer:A generalized disease—prognostic impact of cancer cell dissemination Langenbecks Arch Surg,2008,393(6):911-917.
    [4]Bottger TC, Junginger T. Factors influencing morbidity and mortality after pancreaticoduodenectomy:Critical analysis of 221 resections. World J Surg, 1999,23(2):164-171.
    [5]American Cancer Society. (2008). Cancer facts and figures 2008. Atlanta, GA: Author.
    [6]Makrilia N, Indeck B, Syrigos K, Saif MW:Depression and pancreatic cancer: a poorly understood link.JOP,2009; 10:69-76.
    [7]Jia L, Jiang S-M, Shang Y-Y, Huang Y-X, Li Y-J, Xie D-R, Huang K-H, Zhi F-C:Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion,2010; 82:4-9.
    [8]Fras IL, Litin EM, Pearson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 1967; 123:1553-62.
    [9]Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, Schwarz R:Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care,2010,19(4):522-529.
    [10]Spoletini I, Gianni W, Repetto L, Bria P, Caltagirone C, Bossu P, Spalletta G: Depression and cancer:an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol Hematol,2008,65(2):143-155.
    [11]Barkwell DP. Ascribed meaning:a critical factor in coping and pain attenuation in patients with cancer-related pain. J Palliat Care 1991; 7:5-14.
    [12]Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer:a population-based cohort study. Lancet 1999; 354:1331-6.
    [13]Passik SD, Breitbart WS. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 1996; 78:615-26.
    [14]Block SD. Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life:the art of the possible. JAMA 2001; 285:2898-905.
    [15]杨俊. 陶京,王春友,等.术中腹腔神经丛阻滞术对不能切除的胰腺癌疼痛减轻及生活质量的影响.临床外科杂志,2006,14(2): 11-16.
    [16]Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed pancreas cancer[J]. J Clin Oncol, 1995,13:748-755.
    [17]Pasquini M, Biondi M, Costantini A, et al. Detection and treatment of depressive an d an xiety disorders among cancer patients:feasibility an d preliminary findings from a liaison service in an oncology division Depress Anxiety.2006,23(7):441-48.
    [18]Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13:748-55.
    [19]Pingpank JF, Hoffman JP, Ross EA, et al. effect of preoperative chemoraiotherapy on surgical margin status of resected adenocareinolna of the head of the pancreas Gastrointest Surg,2001,5(2):121-130
    [20]Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-12.
    [21]Spoletini I, Gianni W, Repetto L, Bria P, Caltagirone C, Bossu P, Spalletta G. Depression and cancer:an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol Hematol 2008; 65:143-55.
    [22]Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-12.
    [23]Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemol Ment Health 2007; 3:29.
    [24]Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN. Relationship Between Depression and Pancreatic Cancer in the General Population. Psychosom Med 2003; 65:884-8.
    [25]Shakin EJ, Holland J. Depression and Pancreatic Cancer. J Pain Symptom Manage 1988; 3:194-8.
    [26]Mark J. Boschen, Tian P.S. Oei (2007) Discriminant validity of the MASQ in a clinical sample, Psychiatry Research 150 163-171.
    [27]Xiongzhao Zhu, Randy P. Auerbach, Shuqiao Yao, et al.Psychometric Properties of the Cognitive Emotion Regulation Questionnaire-Chinese Version, Cognition & Emotion,2008,22(2),288-307
    [28]E.de Beurs, M.E.den Hollander-Gijsman, S. Helmich, F.G. Zitman The tripartite model for assessing symptoms of anxiety and depression: Psychometrics of the Dutch version of the mood and anxiety symptoms questionnaire, Behaviour Research and Therapy 2007,45:1609-1617.
    [29]Chavira DA, Stein MB, Bailey K, et al. Comorbidity of generalized social anxiety disorder and depression in a pediatric primary care sample. J Affect Disord,2004,80 (2-3):163.
    [30]Watson, D., Clark, L.A., & Carey, G.Positive and negative affectivity and their relation to anxiety and depressive disorders. Journal of Abnormal Psychology, 1988,97,346-353.
    [31]Clark, L.A., & Watson, D.Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology,1991 100,316-336.
    [32]Watson, D., Clark, L.A., Weber,K., Assenheimer,J.S., Strauss,M.E., & McCormick, R.A. Testing a tripartite model:II. Exploring the symptom structure of anxiety and depression in student,adult and patient samples. Journal of Abnormal Psychology,1995,104,15-25.
    [33]Watson,D.,Weber, K.,Assenheimer, J.S.,Clark,L.A., Strauss,M.E.,& McCormick,R.A. Testing a tripartite model:I. Evaluating the convergent and discriminant validity of anxiety and depressionsymptom scales. Journal of Abnormal Psychology,1995,104,3-14.
    [34]Reidy,J., & Keogh,E.(1997).Testing the discriminant and convergent validity of the Mood and Anxiety Symptoms Questionnaire using a British sample. Personality and Individual Differences,23,337-344.
    [35]E.Keogh and J.Reidy (2000). Exploring the factor structure of the Mood and Anxiety Symptom Questionnaire (MASQ), Journal of Personality Assessment 74,pp.106-125.
    [36]J.Anthony Richey, Christopher J.Lonigan &Beth M.Phillips(2002). Exploratory Factor Analysis of the Mood and Anxiety Symptom Questionnaire (MASQ) in a Youth Sample, the Annual Meeting of the Association for the Advancement of Behavior Therapy.
    [37]Joe A. Buckby, Alison R. Yung, Elizabeth M. Cosgrave and Sue M. Cotton(2007). Distinguishing between anxiety and depressionusing the Mood and Anxiety Symptoms Questionnaire (MASQ), British Journal of Clinical Psychology,46,235-239.
    [38]E.de Beurs, M.E.den Hollander-Gijsman, S. Helmich, F.G. Zitman (2007). The tripartite model for assessing symptoms of anxiety and depression: Psychometrics of the Dutch version of the mood and anxiety symptoms questionnaire, Behaviour Research and Therapy 45 1609-1617.
    [39]Mark J. Boschen, Tian P.S. Oei (2007) Discriminant validity of the MASQ in a clinical sample, Psychiatry Research 150 163-171.
    [40]戴琴,冯正直.抑郁个体对情绪面孔的返回抑制能力不足.心理学报,2009,.41(12):1175-1188
    [41]Avram J Holmes, Ryan Bogdan and Diego A Pizzagalli. Serotonin Transporter Genotype and Action Monitoring Dysfunction:A Possible Substrate Underlying Increased Vulnerability to Depression. Neuropsychopharmacology, 2010,35:1186-1197
    [42]Hankin B L, Abela,J R Z. Depression from childhood through adolescence and adulthood In:Hank, in B L, Abela J R Z (Eds.). Development of psychopathology:A vulnerability-stress perspective. New York,2005: 245-280.
    [43]Abela, J. R. Z. The hopelessness theory of depression:A test of the diathesis-stress and causal mediation components in third and seventh grade children. Journal of Abnormal Child Psychology,2001,29:241-254.
    [44]Abela, J. R. Z., Skitch, S. A., Adams, P., & Hankin, B. L. The timing of (?)ent and child depression:A hopelessness theory perspective. Journal of Clinical Child and Adolescent Psychology,2006,35:253-263.
    [45]Jing Xiao, Shuqiao Yao, Xiongzhao Zhu, John R. Z. Abela, Shu Duan, Shuiping Zhao. A Prospective Study of Cognitive Emotion Regulation Strategies and depressive Symptoms in patients with Essential Hypertension. Clinical and Experimental Hypertension.2011,33(1):63-68.
    [46]Abramson L. Y, Metalsky G I, Alloy L B. Hopelessness depression:a theory-based subtype of depression. Psychological Review,1989,96: 358-372.
    [47]高华,彭新波.抑郁认知易感性的新解释——双重加工模型.心理科学进展2009,17(1):132-137
    [48]Alloy, L. B., Abramson, L. Y., Whitehouse, W. G., Hogan, M. E., Panzarella, C., & Rose, D. T. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology,2006,115:145-156.
    [49]Hankin, B.L., Abramson, L.Y., Moffitt, T.E., Silva, P.A., McGee, R., et al. Development of depression from preadolescence to young adult:Emerging gender differences in a 10-year longitudinal study. Journal of Abnormal Psychology,1998,107:128-140.
    [50]Hankin B L, Abela,J R Z. Depression from childhood through adolescence and adulthood In:Hankin B L, Abela J R Z (Eds.). Development of psychopathology:A vulnerability-stress perspective. New York,2005: 245-280.
    [51]Hankin, B. L., Abramson, L. Y., & Siler, M. (2001). A prospective test of the hopelessness theory of depression in adolescence. Cognitive Therapy and Research,25,607-632.
    [52]Ingram R E, Luxton D D. Vulnerability-stress models. In:Hankin B L, Abela R Z (Eds.) Development of psychopathology:A vulnerability-stress perspective. New York:2005,32-46.
    [53]Abela, J.R.Z., & Sullivan, C. A test of Beck's cognitive diathesis-stress theory of depression in early adolescents. Journal of Early Adolescence,2003,23: 384-404.
    [54]Hankin, B. L., Lakdawalla, Z., Carter, I. L., Abela, J. R. Z., Adams, P. (2007). Are neuroticism, cognitive vulnerabilities and self-esteem overlapping or distinct risks for depression? Evidence from confirmatory factor analyses. Journal of Social & Clinical Psychology,26,29-63.
    [55]周雅,刘翔平,苏洋,冉俐雯.消极偏差还是积极缺乏:抑郁的积极心理学解释.心理科学进展,2010,18(4):590-597.
    [56]Abela, J. R. Z., & Sarin, S. Cognitive vulnerability to hopelessness depression: A chain is only as strong as its weakest link. Cognitive Therapy and Research, 2002,26:811-829.
    [57]Abela, J. R. Z., Aydin, C., & Auerbach, R. P. Operationalizing the "vulnerability"and"stress"components of the hopelessness theory of depression:A multi-wave longitudinal study. Behaviour Research and Therapy,2006,44:1565-1583.
    [58]Abela, J. R. Z., Cristina Aydin and Randy P. Auerbach. Operationalizing the "vulnerability" and "stress" components of the hopelessness theory of depression:A multi-wave longitudinal study. Behaviour Research and Therapy 2006,44(11):1565-1583
    [59]McGorry P.D. The specialist youth mental health model:strengthening the weakest link in the public mental health system. MJA 2007; 187:S53-S56
    [60]Morrisa MC, Jeffrey A. Cieslab and Judy Garbera. A Prospective Study of the Cognitive-Stress Model of Depressive Symptoms in Adolescents. Journal of Abnormal Psychology,2008,117(4):719-734.
    [61]Beatriz Rueda, Ana Maria Perez-Garcia. A prospective study of the effects of psychological resources and depression in essential hypertension. Journal of health psychology.2006; 11; (1) 129-140.
    [62]Lackner, Jeffrey M.; Gellman, Rebecca; Gudleski, Gregory et al. Dysfunctional Attitudes, Gender, and Psychopathology as Predictors of Pain Affect in Patients With Irritable Bowel Syndrome. Journal of Cognitive Psychotherapy.2005; 19(2) 151-161.
    [63]李武,郝伟,苏中华女性海洛因依赖劳教人员功能失调性认知初探[J]中国临床心理学杂志,2004;12(4)408-413
    [64]Koster, EHW, Lissnyder, ED, Derakshan, Raedt, ND. Understanding depressive rumination from a cognitive science perspective:The impaired disengagement hypothesis, a Clinical Psychology Review,31 (2011) 138-145
    [65]Broyd, S. J, Demanuele, C., Debener, S., Helps, S. K., James, C. J., & Sonuga-Barke, E. J. S. Default-mode brain dysfunction in mental disorders:A systematic review.Neuroscience and Biobehavioral Reviews,2009,33, 279-296.
    [66]Jutta Joormann, K. Lira Yoon, Ulrike Zetsche. Cognitive inhibition in depression. Applied and Preventive Psychology,2007,12,128-139
    [67]戴琴,冯正直.不同抑郁状态个体对情绪面孔的评价研究.应用心理学2007,13(4):354-359.
    [68]戴琴,冯正直.抑郁情绪对情绪面孔返回抑制的影响.中国心理卫生杂志, 2008,22(3):164-168
    [69]廖成菊,冯正直,王凤,刘庆英,黄赛.抑郁个体情绪加工与认知控制的相互作用.中国心理卫生杂志,2010,24(5)387-391
    [70]彭晓哲,周晓林.情绪信息与注意偏向.2005,8,13(4):488-496
    [71]Vuilleumier P. Facial expression and selective attention. Current Opinion in Psychiatry,2002,15:291-300
    [72]E.de Beurs, M.E.den Hollander-Gijsman, S. Helmich, F.G. Zitman. The tripartite model for assessing symptoms of anxiety and depression: Psychometrics of the Dutch version of the mood and anxiety symptoms questionnaire, Behaviour Research and Therapy 2007,45,1609-1617.
    [73]Mark J. Boschen, Tian P.S. Oei, Discriminant validity of the MASQ in a clinical sample, Psychiatry.Research 2007,150 163-171'.
    [74]苏巧荣,耿耀国;苏林雁等首发青少年抑郁症患者功能失调性态度研究[J]中国临床心理学杂志,2006;14(5):478-480.
    [75]Alloy, L. B., Abramson, L. Y., Whitehouse, W. G., Hogan, M. E., Panzarella, C., & Rose, D. T. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology,2006,115:145-156.
    [76]Abramson, L. Y., Metalsky, G. I., & Alloy, L. B. Hopelessness depression:A theory-based subtype of depression. Psychological Review,1989,96, 358-372.
    [77]Blischke, W. R, Murthy, D. N. P. Reliability, Modeling, Prediction and Optimization. New York, USA:John Wiley & Sons Inc.,2000.
    [78]Green S. B., Hershberger S. L. Correlated errors in true score models and their effect on coefficient alpha. Structural Equation Modeling,2000,7:251-270
    [79]Bollen, K. A. A new incremental fit index for general structural equation models. Sociological Methods and Research,1989,17:303-316.
    [80]Bentler, P. M. Comparative fit indexes in structural models. Psychological Bulletin.1990,107:238-246.
    [81]Bentler,P.M.& D.G.Bonett..Significance tests and goodness-of-fit in the analysis of covariance structures [J].Psychological Bulletin.1980,88:588-606.
    [82]Bentler, P. M., & Bonett, D. G. (1980).Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin,88,588-606.
    [83]温忠麟,侯杰泰.结构方程模型检验:拟合指数与卡方准则.心理学报,2004,36(2):186-194.
    [84]Chavira DA, Stein MB, Bailey K, et al. Comorbidity of generalized social anxiety disorder and depression in a pediatric primary care sample. J Affect Disord,2004; 80:163-171.
    [85]Gros, D.F, Simms,L.J, Antony, M. M. Psychometric Properties of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA) in Friendship Dyads, Behavior Therapy,2010,41(3):277-284.
    [86]Watson, D., Clark, A.L. & Tellegen, A. (1988). Development and validation of the brief measures of positive and negative affect:The PANAS scales. Journal of Personality and Social Psychology,54,1063-1070.
    [87]Pallant, Julie F,Tennant, Alan, An introduction to the Research measurement model:An example using the Hospital Anxiety and Depression Scale (HADS).British Journal of Clinical Psychology; 2007,46(1):1-18
    [88]J. Goekoop, E.deBeurs, F.Zitman, Four-dimensional structure underlying scales for depression anxiety and retardation:emergence of trapped anger and scale improvements. Comprehensive Psychiatry; 2007,48(2):192-198
    [89]张红,赵庆华原发性高血压患者焦虑抑郁情绪及其应对方式的相关性研究重庆医科大学学报,2007;32(7):749-750
    [90]Patrick J. Smith, James A. Blumenthal, Michael A. Babyak.et al Effects of exercise and weight loss on depressive symptoms among men and women with hypertension. Journal of Psychosomatic Research.2007; 63(5):463-469
    [91]Beatriz Rueda, Ana Maria Perez-Garcia. A prospective study of the effects of psychological resources and depression in essential hypertension. Journal of health psychology.2006; 11; (1) 129-140
    [92]Dja Dozois, At Beck. Cognitive Schemas, Beliefs and Assumptions. Risk Factors in Depression,2008:121-126
    [93]Nolen-Hoeksema, S.. Responses to depression and their effects on the duration of depressive episodes. Journal of Abnormal Psychology,1991,100,569-582.
    [94]Gamefski, N., Teerds, J., Kraaij, V., et al Cognitive emotion regulation strategies and depressive symptoms:Differences between males and females. Personality and Individual Differences,2004,36,267-276.
    [95]Triandis, H. C. The psychological measurement of cultural syndromes. American Psychologist,1996,51,407-415
    [96]XinYin Chen., HuiChang Chen., Violet Kaspar et al Adolescent social,emotional,and school adjustment in mainland China. International Journal of Group Tensions,2000,Vol.29, Nos.1/2
    [97]Bentler, P. M. Comparative fit indexes in structural models. Psychological Bulletin.1990,107:238-246.
    [98]Blankstein KR, Flett GL, Koledin S. The Brief College Student Hassles Scale: Development, validation, and relation with pessimism. Journal of College Student Development,1991,32:258-264.
    [99]Watson, D., Weber, K., Assenheimer, J.S., Clark, L.A., Strauss, M.E., & McCormick, R.A. (1995). Testing a tripartite model:I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. Journal of Abnormal Psychology,104,3-14.
    [100]Geisser, Michael E,Cano, Annmarie, Foran, Heather. Psychometric Properties of the Mood and Anxiety Symptom Questionnaire in Patients with Chronic Pain. The Clinical Journal of Pain,2006; 22:1-9.
    [101]Keogh, E., & Reidy, J. Exploring the factor structure of the mood and anxiety symptom questionnaire (MASQ). Journal of Personality Assessment,2000; 74: 106-125.
    [102]Radolff, L.S. The CES-D scale:A self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385-401.
    [103]Phillips, A.C, Batty, D, Gale, C.R, et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-case and cardiovascular mortality:The Vietnam Experience Study. Psychosom Med. 2009,71:395-403.
    [104]Fountoulakis, K., Iacovides, A., Kleanthous, S., Samolis, S., Kaprinis, S.G., Sitzoglou, K., Kaprinis, G.S., Bech P. Reliability, validity, and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 2001; 1:1-20.
    [105]Zhang J, Norvilitis JM. Measuring Chinese psychological well-being with western developed instruments. J Pers Assess 2002; 79:492-511.
    [106]Gros, D.F, Simms,L.J, Antony, M. M. Psychometric Properties of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA) in Friendship Dyads, Behavior Therapy,2010,41(3):277-284.
    [107]Watson D, Differentiating the Mood and Anxiety Disorders:A Quadripartite Model. Annual Review of Clinical Psychology,2009; 5:221-247.
    [108]Yang X L, Yao S Q, et al Reliability and Validity of the Chinese Version of the Mood and Anxiety Symptoms Questionnaire for University^Students. Chinese Journal of Clinical Psychology,2009,2:25-27.
    [109]Boschen, M.J, Oei, T. P. S. Discriminant validity of the MASQ in a clinical sample, Psychiatry Research,2007; 150:163-171.
    [110]Jacobsa RH, Reineckea MA, Gollana JK, Peter Kane. Empirical evidence of cognitive vulnerability for depression among children and adolescents:A cognitive science and developmental perspective. Clinical Psychology Review, 28(5) 2008:759-782.
    [111]Alloy, L. B., Abramson, L. Y., Hogan, M. E., Whitehouse, W. G., Rose, D. T., Robinson, M. S., et al. (2000). The Temple-Wisconsin cognitive vulnerability to depression project:Lifetime history of Axis I psychopathology in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology,109,403-418.
    [112]Hughes, L.A, Heimberg, R.G, Coles, M.E Brandon E. G, Liebowitz, M.R, Schneier, F.R. Relations of the factors of the tripartite model of anxiety and depression to types of social anxiety, Behaviour Research and Therapy,2006; 44(11):1629-1641.
    [113]郭永红欧阳敏陈琳等,频率适应性起搏器对老年心动过缓患者生活质量的影响.中国临床心理学杂志,2007,15(1),70-70
    [114]Pallant. Julie F, Tennant, Alan, An introduction to the Rasch measurement model:An example using the Hospital Anxiety and Depression Scale (HADS)British Journal of Clinical Psychology; 2007,46(1):1-18
    [115]侯杰泰,成子娟.结构方程模型的应用及分析策略.心理学探新,1999,69(19):54-59
    [116]Eric R.Buhl,Patricia Goodson, Torsten B. Neilands, Structural Equation Modeling: A Primer for Health Behavior Researchers American Journal of Health Behavior; 2007;31(1):74-85.
    [117]Morrisa MC, Jeffrey A. Cieslab and Judy Garbera. A Prospective Study of the Cognitive-Stress Model of Depressive Symptoms in Adolescents. Journal of Abnormal Psychology,2008,117(4):719-734.
    [118]Jacobsa RH, Reineckea MA, Gollana JK, Peter Kane. Empirical evidence of cognitive vulnerability for depression among children and adolescents:A cognitive science and developmental perspective. Clinical Psychology Review, 28(5) 2008:759-782
    [119]徐子燕,李占江,王智明等功能失调性态度,认知偏差与抑郁障碍的关系中国心理卫生杂志200721(7):488-491
    [120]Phillips, A.C, Batty, D, Gale, C.R, et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-case and cardiovascular mortality:The Vietnam Experience Study. Psychosom Med. 2009,71:395-403.
    [121]Fountoulakis, K., Iacovides, A., Kleanthous, S., Samolis, S., Kaprinis, S.G., Sitzoglou, K., Kaprinis, G.S., Bech P. Reliability, validity, and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 2001; 1:1-20.
    [122]Zhang J, Norvilitis JM. Measuring Chinese psychological well-being with western developed instruments. J Pers Assess 2002; 79:492-511.
    [123]Gros, D.F, Simms,L.J, Antony, M. M. Psychometric Properties of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA) in Friendship Dyads, Behavior Therapy,2010,41(3):277-284.
    [124]Abramson, L. Y., Metalsky, G. I., & Alloy, L. B. Hopelessness depression:A theory-based subtype of depression. Psychological Review,1989,96, 358-372.
    [125]Haeffel, G.J., Gibb B E. Metalsky G I. Measuring cognitive vulnerability to depression:Development and validation of the cogniti(?)e style questionnaireClinical Psychology Review,2008,28:824-836.
    [126]Alloy, L. B., Abramson, L. Y., Hogan, M. E., Whitehouse, W. G., Rose, D. T., Robinson, M.S., Kim, R. S., & Lapkin, J. B. The Temple-Wisconsin cognitive vulnerability to depression project:Lifetime history of axis-I psychopathology in individuals at high and low cognitive risk for depression.Journal of Abnormal Psychology,2000,109,403-418.
    [127]. Nolen-Hoeksema, S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology,2000, 109:504-
    [128]511.
    [129]128. Kessler R C. The effects of stressful life events on depression. Annu Rev Psychol,1997,48:191-124.
    [130]129. Kleinman, A. Culture and depression. New England Journal of Medicine, 2004,351,951-953.
    [131]130. Beck, A.T. (1983). Cognitive therapy of depression:New perspectives. In P.J. Clayton & J.E. Barrett (Eds.), Treatment of depression:Old controversies and new approaches. New York:Raven Press.
    [132]Alloy, L. B., Abramson, L. Y, Whitehouse, W. G, Hogan, M. E., Panzarella, C., & Rose, D. T. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology,2006,115:145-156.
    [1]Farrugia ME, Conway R, Simpson DJ, Kurian KM. Paraneoplastic limbic encephalitis. Clin Neurol Neurosurg 2005; 107:128-31.
    [2]Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-12.
    [3]Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemol Ment Health 2007; 3:29
    [4]E.de Beurs, M.E.den Hollander-Gijsman, S. Helmich, F.G. Zitman The tripartite model for assessing symptoms of anxiety and depression: Psychometrics of the Dutch version of the mood and anxiety symptoms questionnaire, Behaviour Research and Therapy 2007,45:1609-1617.
    [5]Chavira DA, Stein MB, Bailey K, et al. Comorbidity of generalized social anxiety disorder and depression in a pediatric primary care sample. J Affect Disord,2004,80(2-3):163.
    [6]Watson, D., Clark, L.A., & Carey, G.Positive and negative affectivity and their relation to anxiety and depressive disorders. Journal of Abnormal Psychology, 1988,97,346-353.
    [7]Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN. Relationship Between Depression and Pancreatic Cancer in the General Population. Psychosom Med 2003; 65:884-8.
    [8]Shakin EJ, Holland J. Depression and Pancreatic Cancer. J Pain Symptom Manage 1988; 3:194-8
    [9]Brown JH, Paraskevas F. Cancer and depression. Cancer presenting with depressive illness:an autoimmune disease? Br JPsychiatry 1982; 141:227-32.
    [10]Alter CL. Palliative and Supportive Care of patients With Pancreatic Cancer. Semin Oncol 1996; 23:229-40.
    [11]Oerlemans ME, van den Akker M, Schuurman AG, Kellen E, Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemol Ment Health 2007; 3:29.
    [12]Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN. Relationship Between Depression and Pancreatic Cancer in the General Population. Psychosom Med 2003; 65:884-8.
    [13]Shakin EJ, Holland J. Depression and Pancreatic Cancer. J Pain Symptom Manage 1988; 3:194-8.
    [14]Mark J. Boschen, Tian P.S. Oei (2007) Discriminant validity of the MASQ in a clinical sample, Psychiatry Research 150163-171.
    [15]杨俊. 陶京,王春友,等.术中腹腔神经丛阻滞术对不能切除的胰腺癌疼痛减轻及生活质量的影响.临床外科杂志,2006,14(2):11-16.
    [16]Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed pancreas cancer[J]. J Clin Oncol,1995,13:748-755.
    [17]Pasquini M, Biondi M, Costantini A, et al. Detection and treatment of depressive an d an xiety disorders among cancer patients:feasibility an d preliminary findings from a liaison service in an oncology division Depress Anxiety.2006,23(7):441-48.
    [18]Passik SD, Breitbart WS. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 1996; 78:615-26.
    [19]Block SD. Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life:the art of the possible. JAMA 2001; 285:2898-905.
    [20]Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13:748-55.
    [21]Pingpank JF, Hoffman JP, Ross EA, et al. effect of preoperative chemoraiotherapy on surgical margin status of resected adenocareinolna of the head of the pancreas Gastrointest Surg,2001,5(2):121-130
    [22]Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-12.
    [23]Spoletini I, Gianni W, Repetto L, Bria P, Caltagirone C, Bossu P, Spalletta G. Depression and cancer:an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol Hematol 2008; 65:143-55.
    [24]Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-12.
    [25]Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice:use of the Distress Thermometer. Cancer 2008; 113:870-8.
    [26]Greenberg DB. Barriers to the Treatment of Depression in Cancer. J Natl Cancer Inst Monogr 2004; 32:127-35.
    [27]Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Jones RD, Berard RM; International Consensus Group on Depression andAnxiety. Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry 2001; 62 (suppl 8):64-7.
    [28]Lloyd-Williams M, Shiels C, Dowrick C. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 2007; 99:259-64.
    [29]American Cancer Society. (2008). Cancer facts and figures 2008. Atlanta, GA: Author.
    [30]Jemal A, Siegel R, Ward E, et al. Cancer statistics,2007. CA Cancer J Clin,2007,57(1):43-66.
    [31]Bogoevski D, Strate T, Yekebas EF, et al. Pancreatic cancer:A generalized disease—prognostic impact of cancer cell dissemination Langenbecks Arch Surg,2008,393(6):911-917.
    [32]Bottger TC, Junginger T. Factors influencing morbidity and mortality after pancreaticoduodenectomy:Critical analysis of 221 resections. World J Surg, 1999,23(2):164-171.
    [33]American Cancer Society. (2008). Cancer facts and figures 2008. Atlanta, GA: Author.
    [34]Makrilia N, Indeck B, Syrigos K, Saif MW:Depression and pancreatic cancer: a poorly understood link. JOP,2009; 10:69-76.
    [35]Jia L, Jiang S-M, Shang Y-Y, Huang Y-X, Li Y-J, Xie D-R, Huang K-H, Zhi F-C:Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion,2010; 82:4-9.
    [36]Fras IL, Litin EM, Pearson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am JPsychiatry 1967; 123:1553-62.
    [37]Hinz A, Krauss O, Hauss JP, Hockel M, Kortmann RD, Stolzenburg JU, Schwarz R:Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care,2010,19(4):522-529.
    [38]Spoletini I, Gianni W, Repetto L, Bria P, Caltagirone C, Bossu P, Spalletta G: Depression and cancer:an unexplored and unresolved emergent issue in elderly patients. Crit Rev Oncol Hematol,2008,65(2):143-155.
    [39]Barkwell DP. Ascribed meaning:a critical factor in coping and pain attenuation in patients with cancer-related pain. J Palliat Care 1991; 7:5-14.
    [40]Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer:a population-based cohort study. Lancet 1999; 354:1331-6.
    [1]K. Ell, B. Quon, D. I. Quinn et al., "Improving treatment of depression among low-income patients with cancer:the design of the ADAPt-C study," GeneralHospital Psychiatry, vol.29, no.3, pp.223-231,2007.
    [2]S. Kaasa,U.Malt, S. Hagen, E.Wist,T.Moum, andA.Kvikstad, "Psychological distress in cancer patients with advanced disease," Radiotherapy and Oncology, vol.27, no.3, pp.193-197,1993.
    [3]J. Zabora, K. Brintzenhofeszoc, B. Curbow, C. Hooker, and S.Piantadosi, "The prevalence of psychological distress by cancer site," Psycho-Oncology, vol.10, no.1,pp.19-28,2001.
    [4]J. Turner, S. Zapart, K. Pedersen, N. Rankin, K. Luxford, and J. Fletcher, "Clinical practice guidelines for the psychosocial care of adults with cancer," Psycho-Oncology, vol.14, no.3, pp.159-173,2005.
    [5]S. Aranda, P. Schofield, L. Weih, D. Milne, P. Yates, and R. Faulkner, "Meeting the support and information needs of women with advanced breast cancer:a randomised controlled trial," British Journal of Cancer, vol.95, no.6, pp.667-673,2006.
    [6]J. H. Rose, R. Radziewicz, K. F. Bowman, and E. E. O'Toole, "A coping and communication support intervention tailored to older patients diagnosed with late-stage cancer," Clinical Interventions in Aging, vol.3, no.1, pp.77-95, 2008.
    [7]M. H. Antoni, S. R.Wimberly, S. C. Lechner et al., "Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer," American' Journal of Psychiatry, vol.163, no.10, pp.1791-1797, 2006.
    [8]H. Seow, C. F. Snyder. L. R. Shugarman et al., "Developing quality indicators for cancer end-of-life care:proceedings from a national symposium," Cancer, vol.115, no.17, pp.3820-3829,2009.
    [9]T. J. Meyer and M. M. Mark, "Effects of psychosocial interventions with adult cancer patients:a meta-analysis of randomized experiments," Health Psychology, vol.14, no.2, pp.101-108,1995.
    [10]S. A. Newell, R. W. Sanson-Fisher, and N. J. Savolainen, "Systematic review of psychological therapies for cancer patients:Overview and recommendations for future research," Journal of the National Cancer Institute, vol.94, no.8, pp. 558-584,2002.
    [11]A. M. Barsevick, C. Sweeney, E. Haney, and E. Chung, "A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer," Oncology nursing forum, vol.29, no.1, pp.73-85,2002.
    [12]B. Rehse and R. Pukrop, "Effects of psychosocial interventions on quality of life in adult cancer patients:Meta analysis of 37 published controlled outcome studies," Patient Education and Counseling, vol.50, no.2, pp.179-186,2003.
    [13]R. J. Uitterhoeve, M. Vernooy, M. Litjens et al., "Psychosocial interventions for patients with advanced cancer:a systematic review of the literature," British Journal of Cancer, vol.91, no.6, pp.1050-1062,2004.
    [14]E. Chow, M. N. Tsao, and T. Harth, "Does psychosocial intervention improve survival in cancer? A meta-analysis," Palliative Medicine, vol.18, no.1, pp. 25-31,2004.
    [15]S. Williams and J. Dale, "The effectiveness of treatment for depression/ depressive symptoms in adults with cancer:a systematic review," British Journal of Cancer, vol.94, no.3, pp.372-390,2006.
    [16]R.L. Osborn, A. C. Demoncada, and M. Feuerstein, "Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors:meta-analyses," International Journal of Psychiatry in Medicine, vol.36, no.1, pp.13-34,2006.
    [17]P. B. Jacobsen and H. S. Jim, "Psychosocial interventions for anxiety and depression in adult cancer patients:achievements and challenges," CA Cancer Journal for Clinicians, vol.58, no.4, pp.214-230,2008.
    [18]A. G. Edwards, N. Hulbert-Williams, and R. D. Neal, "Psychological interventions for women with metastatic breast cancer," The Cochrane Library, no.3,2008.
    [19]D. W. Kissane, B. Grabsch, D. M. Clarke et al., "Supportiveexpressive group therapy for women with metastatic breast cancer:survival and psychosocial outcome froma randomized controlled trial," Psycho-Oncology, vol.16, no.4, pp.277-286,2007.
    [20]M. C. Wilmoth, L. Tulman, E. A. Coleman, C. B. Stewart, and N. Samarel, "Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer," Oncology Nursing Forum, vol.33, no.1, pp.138-144,2006.
    [21]S. Hall, H. Chochinov, R. Harding, S. Murray, A. Richardson, and I. J. Higginson, "A Phase Ⅱ randomised controlled trial assessing the feasibility, acceptability and potential effectiveness of Dignity Therapy for older people in care homes:study protocol," BMC Geriatrics, vol.9, no.1, article 9,2009, http://www.biomedcentral.eom/1471-2318/9/9.
    [22]K. F. Schulz, D. G. Altman, and D. Moher, "CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials," Annals of Internal Medicine, vol.152, no.11, pp.726-732,2010.
    [23]B. L. Andersen, H. C. Yang, W. B. Farrar et al., "Psychologic intervention improves survival for breast cancer patients:a ISRN Nursing 27 randomized clinical trial," Cancer, vol.113, no.12, pp.3450-3458,2008.
    [24]L. J. Edgar, J. Remmer, Z. Rosberger, and B. Rapkin, "Evaluating a volunteer cancer support service," Journal of Psychosocial Oncology, vol.21, no.1, pp. 53-72,2003.
    [25]J. J. Miller, M. H. Frost, T. A. Rummans et al., "Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary intervention," Journal of Psychosocial Oncology, vol.25, no.4, pp.105-119,2007.
    [26]C. Pitceathly, P. Maguire, I. Fletcher, M. Parle, B. Tomenson, and F. Creed, "Can a brief psychological intervention prevent anxiety or depressive disorders in cancer patients? A randomised controlled trial," Annals of Oncology, vol.20, no.5, pp.928-934,2008.
    [27]L.D.Butler, C. Koopman, E. Neri et al., "Effects of Supportive-Expressive Group Therapy on Pain inWomenWithMetastatic Breast Cancer," Health Psychology, vol.28, no.5, pp.579-587,2009.
    [28]T. A. Rummans, M. M. Clark, J. A. Sloan et al., "Impacting quality of life for patients with advanced cancer with a structuredmultidisciplinary intervention:a randomized controlled trial," Journal of Clinical Oncology, vol.24, no.4, pp. 635-642,2006.
    [29]S. Manne, J. S. Ostroff, and G. Winkel, "Social-cognitive processes as moderators of a couple-focused group intervention for women with early stage breast cancer," Health Psychology, vol.26, no.6, pp.735-744,2007.
    [30]K. Ell, B. Xie, B. Quon, D. I. Quinn, M. Dwight-Johnson, and P. J. Lee, "Randomized controlled trial of collaborative care management of depression among low-income patients with cancer," Journal of Clinical Oncology, vol.26, no.27, pp.4488-4496,2008.
    [31]B. L. Andersen,W. B. Farrar, D. Golden-Kreutz et al., "Distress reduction from a psychological intervention contributes to improved health for cancer patients," Brain, Behavior, and Immunity, vol.21, no.7, pp.953-961,2007.
    [32]M. H. Antoni, S. Lechner, A. Diaz et al., "Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer," Brain, Behavior, and Immunity, vol. 23, no.5, pp.580-591,2008.
    [33]A. Girgis, S. Breen, F. Stacey, and C. Lecathelinais, "Impact of two supportive care interventions on anxiety, depression, quality of life, and unmet needs in patients with nonlocalized breast and colorectal cancers," Journal of ClinicalOncology, vol.27, no.36, pp.6180-6190,2009.
    [34]R. L. Kravitz, D. J. Tancredi, T. Grennan et al., "Cancer health empowerment for living without pain (Ca-HELP):effects of a tailored education and coaching intervention on pain and impairment," Pain, vol.152, no.7, pp.1572-1582, 2011.
    [35]S. L.Manne, G.Winkel, S. Rubin et al., "Mediators of a Coping and Communication-Enhancing Intervention and a Supportive Counseling Intervention Among Women Diagnosed With Gynecological Cancers," Journal of Consulting and Clinical Psychology, vol.76, no.6, pp.1034-1045,2008.
    [36]D. Spiegel, L. D. Butler, J. Giese-Davis et al., "Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer:a randomized prospective trial,"Cancer, vol.110, no.5, pp.1130-1138,2007.
    [37]J. Walker, J. Cassidy, and M. Sharpe, "The third symptom management research trial in oncology (SMaRT Oncology-3):a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (Depression Care for People with Lung Cancer) to usual care, compared to usual care alone in patients with lung cancer," Trials, vol.10, article 1745, p.92,2009, http://www.trialsjournal.com/content/10/1/92.
    [38]B. L. Andersen, R. A. Shelby, and D. M. Golden-Kreutz, "RCT of a psychological intervention for patients with cancer:i. mechanisms of change," Journal of Consulting and Clinical Psychology, vol.75, no.6, pp.927-938, 2007.
    [39]E. Boesen, S. Boesen, S. Christensen, and C. Johansen, "Comparison of participants and non-participants in a randomized psychosocial intervention study among patients with malignant melanoma," Psychosomatics, vol.48, no. 6, pp.510-516,2007.
    [40]S. Fukui, K. Ogawa, M. Ohtsuka, and N. Fuku, "A randomized study assessing the efficacy of communication skill training on patients' psychologic distress and coping nurses' communication with patients just after being diagnosed with cancer," Cancer, vol.113, no.6, pp.1462-1470,2008.
    [41]C. B. Powell, A. Kneier, L. M. Chen,M. Rubin, C. Kronewetter, and E. Levine, "A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic," Gynecologic Oncology, vol. 111,no.1, pp.137-143,2008.
    [42]J. H. Rose, K. F. Bowman, R. M. Radziewicz, S. A. Lewis, and E. E. O'Toole, "Predictors of engagement in a coping and communication support intervention for older patients with advanced cancer," Journal of the American Geriatrics Society, vol.57, no.2, pp. S296-S299,2009.
    [43]F. I. Fawzy and N. W. Fawzy, "A structured psychoeducational intervention for cancer patients," General Hospital Psychiatry, vol.16, no.3, pp.149-192, 1994.
    [44]E. H. Boesen, L. Ross, and K. Frederiksen, "A psycho-educational intervention for patients with cutaneous malignant melanoma:a replication study of Fawzy et al," Clinical Oncology, vol.23, pp.1270-1277,2005.
    [45]A. Zabalegui, S. Sanchez, P. D. Sanchez, and C. Juando, "Integrative literature reviews and meta-analyses:nursing and cancer support groups," Journal of Advanced Nursing, vol.51, no.4, pp.369-381,2005.
    [46]R. M. Radziewicz, J. H. Rose, K. F. Bowman, R. A. Berila, E. E. O'Toole, and B. Given, "Establishing treatment fidelity in a coping and communication support telephone intervention for aging patients with advanced cancer and their family caregivers," Cancer Nursing, vol.32, no.3, pp.193-202,2009

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700